PURE CALM
DEAD

Serial Number

87832606

Owner

Pure Green

First Use Date

Feb 1, 2018

Filing Date

Mar 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PURE CALM Trademark

Serial Number: 87832606 • Registration: 5585603

PURE CALM is a trademark filed by Pure Green on March 13, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Pure Green (4 trademarks)

4761 Tara Court
W. bloomfield, MI 48323

Entity Type: 16

Trademark Details

Filing Date

March 13, 2018

Registration Date

October 16, 2018

First Use Anywhere

February 1, 2018

First Use in Commerce

February 1, 2018

Published for Opposition

July 31, 2018

Cancellation Date

May 2, 2025

Goods & Services

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention of nervousness; Pharmaceutical preparations for the treatment and prevention of nervousness; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for the treatment of nervous conditions; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for nervousness; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Analgesic and muscle relaxant pharmaceutical preparations; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bandages impregnated with calming agents; Dermatological pharmaceutical products; Dextrins for pharmaceutical use; Digestives for pharmaceutical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with calming agents; Plant extracts for medical, veterinary and pharmaceutical purposes; Syringes sold filled with calming agents; Therapeutic pharmaceutical for the treatment of nervousness; Veterinary pharmaceutical preparations for the prevention of agitation; Veterinary pharmaceutical preparations for the treatment of nervousness; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
May 2, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 16, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 31, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 31, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 11, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2018 NWOS
NEW APPLICATION ENTERED
Mar 16, 2018 NWAP